Causes and treatment of oedema in patients with heart failure. (Q38074093)

28 August 2017

title

Causes and treatment of oedema in patients with heart failure. (English)

1 reference

28 August 2017

0 references

Andrew L Clark

1

1 reference

28 August 2017

John G F Cleland

series ordinal

2

1 reference

28 August 2017

publication date

15 January 2013

1 reference

Nature Reviews Cardiology

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

156-170

1 reference

The national heart failure audit for England and Wales 2008-2009.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

On the Absorption of Fluids from the Connective Tissue Spaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Acute dyspnoea resulting from pulmonary oedema as the first sign of a phaeochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Pathogenesis of pulmonary edema: learning from high-altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The value of edema fluid protein measurement in patients with pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Acute heart failure as "acute endothelitis"--Interaction of fluid overload and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Pulmonary edema develops after recurrent obstructive apneas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Relationship between sodium intake and sleep apnea in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The role of pulmonary lymphatics in the clearance of hydrostatic pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Pulmonary vascular changes associated with isolated mitral stenosis in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Acute pulmonary oedema: clinical characteristics, prognostic factors, and in‐hospital management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The unique role of diamorphine in British medical practice: a survey of general practitioners and hospital doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Morphine-induced venodilation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Morphine-induced cardiogenic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Review article: lack of effect of opiates in the treatment of acute cardiogenic pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Continuous positive pressure ventilation in the management of eight cases of acute pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Prehospital non-invasive ventilation for acute cardiogenic pulmonary oedema: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Noninvasive ventilation in acute cardiogenic pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Renal and Extrarenal Hemodynamic Effects of Furosemide in Congestive Heart Failure after Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The insufficient nitrate response: patients' characterization and response to beta and calcium blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The Role of Furosemide in the Treatment of Left Ventricular Dysfunction Associated with Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Randomized placebo controlled trial of furosemide on subjective perception of dyspnoea in patients with pulmonary oedema because of hypertensive crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Acute effects of low and high intravenous doses of furosemide on myocardial function in anuric haemodialysis patients: a tissue Doppler study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Rapid improvement of acute pulmonary edema with sublingual captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

RITZ-5: randomized intravenous TeZosentan (an endothelin-A/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT-2, MIRACLE-ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effect of nesiritide in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Lung epithelial fluid transport and the resolution of pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Upregulation of alveolar epithelial active Na+ transport is dependent on beta2-adrenergic receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Alveolar epithelial beta2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Cardioprotective effects in aged spontaneously hypertensive rats due to chronic stimulation/activation of sGC without hypotension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Novel cardiac myosin activators for acute heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Evolution and the cardiac patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Interactions between intrarenal epinephrine receptors and the renal baroreceptor in the control of PRA in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Symptoms experienced in the last six months of life in patients with end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Keeping the maintenance of daily life in spite of chronic heart failure. A qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Thirst in the elderly with and without heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effect of aging on regional cerebral blood flow responses associated with osmotic thirst and its satiation by water drinking: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The relationship between elevated water intake and oedema associated with congestive cardiac failure in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Hemodynamic and plasma atrial natriuretic peptide responses to acute digitalis therapy in patients with normal and impaired left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Thigh-Length Versus Below-Knee Stockings for Deep Venous Thrombosis Prophylaxis After Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Influence of progressive renal dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Renal circulatory effects of adenosine in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Combination diuretic therapy in severe congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Pharmacology of diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Clinical comparison of frusemide with bendrofluazide, mersalyl, and ethacrynic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Loop Diuretics for Chronic Renal Insufficiency: A Continuous Infusion Is More Efficacious Than Bolus Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Diuretic strategies in patients with acute decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Combination diuretic treatment in severe heart failure: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

DIGITALIS IN HEART FAILURE WITH NORMAL RHYTHM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Early ultrafiltration in patients with decompensated heart failure and diuretic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Ultrafiltration in decompensated heart failure with cardiorenal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind st

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Telemedicine and remote management of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The atrial fibrillation paradox of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2012.191

10.1038/NRCARDIO.2012.191

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference